Gary Meininger

Gary Meininger

Hoofd Techniek/Wetenschap/O&O bij SANA BIOTECHNOLOGY, INC.
Health Technology
Consumer Services

Profiel

Gary Meininger currently works at Joslin Diabetes Center, Inc., as Director from 2024 and Sana Biotechnology, Inc., as Chief Medical Officer from 2023.
Dr. Meininger also formerly worked at Johnson & Johnson, as Vice President from 2010 to 2019, Vertex Pharmaceuticals, Inc., as Senior Vice President & Head-Clinical Development from 2020 to 2023, and Merck Research Laboratories Massachusetts LLC, as Principal from 2002 to 2010.
Dr. Meininger received his undergraduate degree from State University of New York at Binghamton and doctorate degree from New York University School of Medicine.

Actieve functies van Gary Meininger

BedrijvenFunctieBegin
SANA BIOTECHNOLOGY, INC. Hoofd Techniek/Wetenschap/O&O 10-04-2023
Directeur/Bestuurslid 01-10-2024

Eerdere bekende functies van Gary Meininger

BedrijvenFunctieEinde
VERTEX PHARMACEUTICALS INCORPORATED Hoofd Techniek/Wetenschap/O&O 01-03-2023
JOHNSON & JOHNSON Corporate Officer/Principal 01-02-2019
Corporate Officer/Principal 01-07-2010
Ervaring van Gary Meininger in detail bekijken

Opleiding van Gary Meininger

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

81

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit7

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

  1. Beurs
  2. Insiders
  3. Gary Meininger